You are here: Industry Insights > merger

News List

Aquinox, Neoleukin Therapeutics Announce Merger Agreement contractpharma
August 07, 2019
Combined company capitalized with approximately $65M to develop novel immunotherapies.
Emmaus Life Sciences Completes Merger americanpharmaceuticalreview
July 19, 2019
Emmaus Life Sciences and MYnd Analytics announced they have completed the previously announced merger transaction, following stockholder approval by both companies on July 9.
BMS to divest Otezla for approval of $74bn merger with Celgene pharmaceutical-technology
June 26, 2019
Bristol-Myers Squibb (BMS) has offered to divest prescription medicine Otezla in order to receive approval for its $74bn merger with Celgene from the US Federal Trade Commission (FTC).
85% shares voted to date to support merger of Flex Pharma with Salarius Pharma biospectrumasia
June 18, 2019
Flex Pharma adjourned the special meeting until July 12, 2019 in order to provide shareholders with more time to complete proxies and vote their shares.
Bristol-Myers Squibb, Celgene shareholders vote to back proposed $74-billion merger firstwordpharma
April 14, 2019
Shareholders have voted to approve Bristol-Myers Squibb's roughly $74-billion deal to acquire Celgene, the companies announced separately on Friday.
Roche forced to extend Spark tender offer as investors sue over $4.3B merger fiercepharma
April 04, 2019
Roche’s $114.50-per-share offer for Spark Therapeutics represents a whopping 122% premium to the gene specialist’s
NLS Pharmaceutics Announces the Completion of the Merger between NLS Pharma Ltd., NLS-1 Pharma Ltd. and NLS-0 Pharma, Unifying the Global Operations and Development of Nolazol firstwordpharma
March 20, 2019
NLS Pharmaceutics Ltd (NLS), a Swiss biotech firm focusing on the development of novel treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and other cognitive disorders and impairments, today announced the closing of the merger of NLS Pharma Lt
Flex-Salarius merger to focus on epigenetic cancer therapies pharmaceutical-technology
January 07, 2019
Flex Pharmaceuticals has announced it has entered into a definitive merger agreement with Salarius Pharmaceuticals for an undisclosed sum. The board of directors of both companies have approved the merger.....
BMS acquires Celgene for an equity value of $74bn pharmaceutical-technology
January 04, 2019
Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to acquire Celgene via a cash and stock transaction with an equity value of $74bn; Celgene shares have been valued at $102.43 per share.
Akorn searches for new CEO after failed Fresenius merger pharmaphorum
December 12, 2018
US generics firm Akorn is searching for a new CEO in the wake of a failed merger with Fresenius Kabi last year.Akorn had been set to merge with Fresenius Kabi in 2017...

Previous page 1 2 3 4 Next page